We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-10.03%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.87B
AUM Growth
-$850M
Cap. Flow
-$474M
Cap. Flow %
-25.38%
Top 10 Hldgs %
35.79%
Holding
428
New
80
Increased
61
Reduced
58
Closed
70

Top Buys

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$45.9M
2
HES
Hess
HES
+$39.1M
3
LEN icon
Lennar Class A
LEN
+$23.6M
4
ERO icon
Ero Copper
ERO
+$21.2M
5
GCTS
GCT Semiconductor Holding
GCTS
+$19.8M

Top Sells

Rank Stock Value
1
FE icon
FirstEnergy
FE
+$93.6M
2
HLF icon
Herbalife
HLF
+$42.6M
3
MMP
Magellan Midstream Partners, L.P.
MMP
+$39.1M
4
ADNT icon
Adient
ADNT
+$30.4M
5
AMZN icon
Amazon
AMZN
+$26.7M

Sector Composition

Rank Sector Weight
1 Financials 26.8%
2 Healthcare 19.15%
3 Consumer Discretionary 8.96%
4 Communication Services 8.58%
5 Industrials 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIOA
26
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
$19.6M 1.05%
2,000,000
– –
BHAC
27
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$19.5M 1.04%
1,980,000
+80,000
+4% +$786K
LITT
28
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
$19.4M 1.04%
1,999,999
– –
HWKZ
29
DELISTED
Hawks Acquisition Corp
HWKZ
$19.3M 1.03%
1,980,000
+700,000
+55% +$6.8M
MGTX icon
30
MeiraGTx Holdings
MGTX
$1.14B
$18.8M 1%
1,355,000
– –
MRNS
31
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$18.1M 0.97%
1,932,829
– –
IRS
32
IRSA Inversiones y Representaciones
IRS
$1.26B
$17M 0.91%
3,270,167
-16,736
-0.5% -$78.7K
ATRA icon
33
Atara Biotherapeutics
ATRA
$80M
$17M 0.91%
73,200
+1,951
+3% +$621K
GTAC
34
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
$15.3M 0.82%
1,535,000
+1,030,000
+204% +$10.2M
RKTA
35
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
$14.7M 0.79%
1,500,000
– –
TCOA
36
DELISTED
Zalatoris Acquisition Corp.
TCOA
$14.5M 0.78%
+1,485,000
New +$14.5M
PANA
37
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$14.4M 0.77%
1,480,000
– –
CND
38
DELISTED
Concord Acquisition Corp.
CND
$13.3M 0.71%
1,340,000
+1,140,000
+570% +$11.4M
CRESY
39
Cresud
CRESY
$779M
$12.8M 0.69%
1,624,159
-254,000
-14% -$1.5M
KG
40
Kestrel Group
KG
$73M
$12.3M 0.66%
255,950
– –
SRSA
41
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$11.9M 0.64%
1,200,000
– –
CLDI icon
42
Calidi Biotherapeutics
CLDI
$2.2M
$11.9M 0.64%
625
+521
+501% +$9.85M
ORIA
43
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$11.7M 0.63%
1,199,000
– –
USO icon
44
CALL
United States Oil Fund
USO
$1.82B
$10.7M 0.58%
145,000
– –
IVVD icon
45
Invivyd
IVVD
$170M
$10.7M 0.57%
2,350,000
+1,730,000
+279% +$10.6M
APMI
46
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
$10.6M 0.57%
1,099,996
+100,000
+10% +$967K
TRTN
47
DELISTED
Triton International Limited
TRTN
$10.2M 0.54%
145,000
+35,000
+32% +$2.26M
SQZ
48
DELISTED
SQZ Biotechnologies Company
SQZ
$10.1M 0.54%
2,098,815
+246,680
+13% +$1.57M
IMTX icon
49
Immatics
IMTX
$1.28B
$10.1M 0.54%
1,260,000
+75,955
+6% +$692K
DRAY
50
DELISTED
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
$9.89M 0.53%
999,999
– –
1
2
3 4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, 683 Capital Management held 428 positions worth $1.87B, down 31% from $2.72B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

683 Capital Management withdrew a net $474M in Q1 2022, closing 70 positions and reducing 58 holdings. Its most notable exit was Adient, an estimated $30.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, 683 Capital Management opened a new position in Hess worth $44.2M.

  • 683 Capital Management's largest Q1 2022 buy was Hess: 412,500 shares worth $44.2M.
  • 683 Capital Management added most to Carvana in Q1 2022, an estimated $45.9M increase.
  • 683 Capital Management's biggest Q1 2022 reduction was FirstEnergy, cutting an estimated $93.6M.
  • 683 Capital Management fully exited Adient in Q1 2022, selling an estimated $30.4M.
  • 683 Capital Management's ten largest holdings make up 36% of its $1.87B portfolio in Q1 2022.
  • 683 Capital Management opened 80 new positions and closed 70 in Q1 2022.
  • 683 Capital Management's portfolio value fell 31% quarter-over-quarter to $1.87B.

Based on 683 Capital Management's 13F filing for Q1 2022, filed 16 May 2022.